Next Article in Journal
Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection
Next Article in Special Issue
Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster
Previous Article in Journal
Assessing the Impact of COVID-19 Vaccination on Preterm Birth: A Systematic Review with Meta-Analysis
Previous Article in Special Issue
Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
 
 
Article

Article Versions Notes

Vaccines 2024, 12(1), 103; https://doi.org/10.3390/vaccines12010103
Action Date Notes Link
article xml file uploaded 20 January 2024 08:52 CET Original file -
article xml uploaded. 20 January 2024 08:52 CET Update -
article pdf uploaded. 20 January 2024 08:52 CET Version of Record https://www.mdpi.com/2076-393X/12/1/103/pdf-vor
article supplementary file uploaded. 20 January 2024 08:52 CET - https://www.mdpi.com/2076-393X/12/1/103#supplementary
article html file updated 20 January 2024 08:53 CET Original file -
article xml file uploaded 23 January 2024 09:06 CET Update -
article xml uploaded. 23 January 2024 09:06 CET Update https://www.mdpi.com/2076-393X/12/1/103/xml
article pdf uploaded. 23 January 2024 09:06 CET Updated version of record https://www.mdpi.com/2076-393X/12/1/103/pdf
article html file updated 23 January 2024 09:09 CET Update https://www.mdpi.com/2076-393X/12/1/103/html
Back to TopTop